In addition, there was a non-significant trend towards reduced plasma levels of TGF-β, renowned for its negative effect on anti-tumor immunity by suppressing immune effector cell functions of, amongst others, CTLs, CD4+ T cells and NK cells while promoting the generation and recruitment of Tregs (56–61). Here, TGFB1 is linked to neoplasm.